BDX
55
3
PAYX
47
5
DRI
66
2
IBM
57
2
EFX
61
3
TRV
65
7
HP
28
-12
ORLY
65
4
PG
68
4
UHS
62
8
RCL
70
5
STX
53
3
PRU
60
3
F
56
2
M
33
8
OI
46
3
HPE
34
17
URI
48
8
PLD
37
-9
PNR
45
4
BDX
55
3
PAYX
47
5
DRI
66
2
IBM
57
2
EFX
61
3
TRV
65
7
HP
28
-12
ORLY
65
4
PG
68
4
UHS
62
8
RCL
70
5
STX
53
3
PRU
60
3
F
56
2
M
33
8
OI
46
3
HPE
34
17
URI
48
8
PLD
37
-9
PNR
45
4
Financhill
Back

TransMedics Group Stock Predictions

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52

TMDX
TransMedics Group

Last Price:
$68.95
Seasonality Move:
23.66%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

TransMedics Group Stock Forecast

  • Over the next 52 weeks, TransMedics Group has on average historically risen by 82.4% based on the past 5 years of stock performance.
  • TransMedics Group has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is TransMedics Group Stock Undervalued?
    The current TransMedics Group [TMDX] share price is $67.75. The Score for TMDX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • TMDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will TransMedics Group Stock Go Up Next Year?

  • Over the next 52 weeks, TransMedics Group has on average historically risen by 82.4% based on the past 5 years of stock performance.

TransMedics Group Stock Rating

Buy
52
TransMedics Group (TMDX) is a Buy

Is TransMedics Group overpriced?

  • TransMedics Group has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

TransMedics Group Stock Price History

Is TMDX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TMDX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
transmedics.com

52-Week Data

52-Week High:
177.37
52-Week Low:
55.00

Prediction Charts

Market Cap:
2.3B
Price in USD:
67.75
Volume:
927.6K
Beta:
1.99

Technical Analysis

SMA50:
68.18
SMA100:
76.00
SMA200:
112.50
52-Wk Change:
-10.78%

Stock Predictions

  • Is TransMedics Group stock public?
    Yes, TransMedics Group is a publicly traded company.
  • What is the TransMedics Group stock quote today?
    The TransMedics Group stock price is 67.75 USD today.
  • How to buy TransMedics Group stock online?
    You can buy TransMedics Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-25 74.92 73.00 76.33 72.37
Feb-26 72.92 73.76 76.64 72.08
Feb-27 75.00 72.12 77.18 72.06
Feb-28 73.66 76.34 80.22 73.00
Mar-3 76.43 69.33 77.17 68.46
Mar-4 66.00 69.11 69.76 63.29
Mar-5 69.60 67.44 69.98 66.31
Mar-6 64.36 65.29 66.44 62.07
Mar-7 65.45 67.46 68.20 63.64
Mar-11 65.73 67.68 68.71 65.53
Mar-12 69.54 67.08 69.67 66.25
Mar-13 67.10 64.35 67.84 62.62
Mar-14 65.72 68.51 68.79 65.26
Mar-17 68.43 67.75 69.67 67.24

TransMedics Group Earnings

TransMedics Group Earnings Report: Per Share TransMedics Group Earnings Q1 Q2 Q3 and Q4 last year and next year.

TransMedics Group Forecast Revenue Growth

TransMedics Group Stock Analysis: Historical quarterly revenues per share for TransMedics Group and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.08 per share, an increase this year of $0.54 per share, and an increase next year of $0.73 per share.

* TransMedics Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.